Tuberculosis diagnosis and treatment under uncertainty
Rachel Cassidy and
Charles Manski
Additional contact information
Rachel Cassidy: Institute for Fiscal Studies, London, WC1E 7AE, United Kingdom
Proceedings of the National Academy of Sciences, 2019, vol. 116, issue 46, 22990-22997
Abstract:
In 2017, 1.6 million people worldwide died from tuberculosis (TB). A new TB diagnostic test—Xpert MTB/RIF from Cepheid—was endorsed by the World Health Organization in 2010. Trials demonstrated that Xpert is faster and has greater sensitivity and specificity than smear microscopy—the most common sputum-based diagnostic test. However, subsequent trials found no impact of introducing Xpert on morbidity and mortality. We present a decision-theoretic model of how a clinician might decide whether to order Xpert or other tests for TB, and whether to treat a patient, with or without test results. Our first result characterizes the conditions under which it is optimal to perform empirical treatment; that is, treatment without diagnostic testing. We then examine the implications for decision making of partial knowledge of TB prevalence or test accuracy. This partial knowledge generates ambiguity, also known as deep uncertainty, about the best testing and treatment policy. In the presence of such ambiguity, we show the usefulness of diversification of testing and treatment.
Keywords: public health; medical decision making; decision under ambiguity; tuberculosis; diagnosis and treatment (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (5)
Downloads: (external link)
http://www.pnas.org/content/116/46/22990.full (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nas:journl:v:116:y:2019:p:22990-22997
Access Statistics for this article
More articles in Proceedings of the National Academy of Sciences from Proceedings of the National Academy of Sciences
Bibliographic data for series maintained by PNAS Product Team ().